The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States
- PMID: 19107383
- PMCID: PMC2728788
- DOI: 10.1007/s00198-008-0821-x
The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States
Abstract
Using national Medicare data from 1999-2006, we evaluated the relationship between travel distance and receipt of dual-energy X-ray absorptiometry (DXA). After adjusting for potentially confounding factors, travel distance was strongly associated with DXA testing. Rural residents were most strongly dependent on the availability of DXAs performed in physician offices.
Introduction: Medicare reimbursement for DXAs performed in non-facility settings (e.g., physician offices) decreased in 2007. With declining reimbursement, some DXA providers may cease providing this service, which would increase travel distance for some people. The impact of travel distance on access to DXA is unclear.
Methods: Using national Medicare data, we identified claims for DXA to evaluate trends in the number and locations of DXAs performed. Travel distance was the distance from beneficiaries' residence and the nearest DXA provider. Binomial regression evaluated the relationship between travel distance and receipt of DXA.
Results: In 2006, 2.9 million DXAs were performed, a 103% increase since 1999. In 2005-2006, 8.0% of persons were tested at non-facility sites versus 4.2% at facility sites. The remainder (88%) had no DXA. Persons traveling 5-9, 10-24, 25-39, and 40-54, and > or = 55 miles were less likely to receive DXA (adjusted risk ratios = 0.92, 0.79, 0.43, 0.32, and 0.26, respectively, < 5 miles referent). Rural residents were more dependent than urban residents on the availability of DXA from non-facility providers.
Conclusion: Approximately two-thirds of DXAs in 2005-2006 were performed in non-facility settings (e.g., physician offices). Rural residents would have preferentially reduced access to DXA if there were fewer non-facility sites.
Figures
Similar articles
-
Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes.J Bone Miner Res. 2012 Apr;27(4):858-64. doi: 10.1002/jbmr.1534. J Bone Miner Res. 2012. PMID: 22190195
-
Overuse of short-interval bone densitometry: assessing rates of low-value care.Osteoporos Int. 2014 Sep;25(9):2307-11. doi: 10.1007/s00198-014-2725-2. Epub 2014 May 9. Osteoporos Int. 2014. PMID: 24809808 Free PMC article.
-
Regional variation in the denial of reimbursement for bone mineral density testing among US Medicare beneficiaries.J Clin Densitom. 2008 Oct-Dec;11(4):568-74. doi: 10.1016/j.jocd.2008.07.004. Epub 2008 Sep 12. J Clin Densitom. 2008. PMID: 18789740 Free PMC article.
-
Dual-energy X-ray absorptiometry in clinical practice: new guidelines and concerns.Curr Opin Rheumatol. 2011 Jul;23(4):385-8. doi: 10.1097/BOR.0b013e328347d90c. Curr Opin Rheumatol. 2011. PMID: 21637082 Review.
-
Vertebral Fracture Assessment by dual-energy X-ray absorptiometry: insurance coverage issues in the United States. A White Paper of the International Society for Clinical Densitometry.J Clin Densitom. 2007 Jul-Sep;10(3):227-38. doi: 10.1016/j.jocd.2007.04.002. Epub 2007 Jun 28. J Clin Densitom. 2007. PMID: 17604666 Review.
Cited by
-
Automated osteoporosis classification and T-score prediction using hip radiographs via deep learning algorithm.Ther Adv Musculoskelet Dis. 2024 Apr 24;16:1759720X241237872. doi: 10.1177/1759720X241237872. eCollection 2024. Ther Adv Musculoskelet Dis. 2024. PMID: 38665415 Free PMC article.
-
Development and cross-validation of a circumference-based predictive equation to estimate body fat in an active population.Obes Sci Pract. 2024 Apr 18;10(2):e747. doi: 10.1002/osp4.747. eCollection 2024 Apr. Obes Sci Pract. 2024. PMID: 38646612 Free PMC article.
-
Did Access to Ambulatory Care Moderate the Associations Between Visit Mode and Ancillary Services Utilization Across the COVID-19 Pandemic Period?Med Care. 2023 Apr 1;61(Suppl 1):S39-S46. doi: 10.1097/MLR.0000000000001832. Epub 2023 Mar 9. Med Care. 2023. PMID: 36893417 Free PMC article.
-
Comparison of Quantitative Computed Tomography and Dual X-Ray Absorptiometry: Osteoporosis Detection Rates in Diabetic Patients.Cureus. 2022 Mar 13;14(3):e23131. doi: 10.7759/cureus.23131. eCollection 2022 Mar. Cureus. 2022. PMID: 35433140 Free PMC article.
-
Advances in Phenotyping Obesity and in Its Dietary and Pharmacological Treatment: A Narrative Review.Front Nutr. 2022 Feb 15;9:804719. doi: 10.3389/fnut.2022.804719. eCollection 2022. Front Nutr. 2022. PMID: 35242796 Free PMC article. Review.
References
-
- Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22(3):465–75. - PubMed
-
- Lewiecki EM, Watts NB, McClung MR, et al. Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab. 2004;89(8):3651–5. - PubMed
-
- Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348:1535–41. - PubMed
-
- Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809–22. - PubMed
-
- Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA. 1999;282:1344–1352. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
